CD40-Ligand lacking native-pattern glycosylation
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 29, 2008
Grant Date -
Jul 31, 2003
app pub date -
Jul 19, 2002
filing date -
Oct 25, 1991
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
There is disclosed a polypeptide (CD40-L) and DNA sequences, vectors and transformed host cells useful in providing CD40-L polypeptides. More particularly, this invention provides isolated human and murine CD40-L polypeptides that bind to the extracellular binding region of a CD40 receptor and lack native-pattern glycosylation.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully